The largest database of trusted experimental protocols

Aβ31 35

Manufactured by Abcam

Aβ31-35 is a peptide product that corresponds to the 31-35 amino acid sequence of the amyloid-beta (Aβ) protein. This peptide is commonly used in research applications.

Automatically generated - may contain errors

2 protocols using aβ31 35

1

Mouse Model for Alzheimer's Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six‐to‐eight‐week‐old male C57BL/6 mice (18‐22 g) were obtained from the Research Animal Center of Shanxi Medical University with approval of the Shanxi Animal Research Ethics Committee, and the procedures were performed in accordance with ethical guidelines. The approval code is SYXK2015‐0001. The mice were placed in an environment with appropriate temperature and humidity, and food was provided ad libitum during the entire study.
The main reagents for the experiment included Aβ31‐35 (Abcam), D‐Ser2‐oxyntomodulin (provided by Professor Christian Hölscher), Bmal1 antibody (Abcam), Per2 antibody (Santa Cruz Biotechnology), and GLP‐1R antibody (Abcam).
+ Open protocol
+ Expand
2

Hippocampal Nerve Cell Line Synchronization and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse hippocampal nerve cell line (HT22) were purchased from Guangzhou Jennio Biotechnology Co., Ltd. The HT22 cells were cultured in Dulbecco's Modified Eagle Medium complete medium (HyClone) supplemented with 10% foetal bovine serum (FBS; Sciencell) and were kept in a constant‐temperature incubator at 37°C and 5% CO2. After adhesion, cells with 80% density and adequate growth conditions were selected for the synchronization treatment in each group. The complete medium for culturing cells was replaced with a starvation medium supplemented with 1% FBS. HT22 cells were synchronized by serum deprivation (1% FBS) for 1 h, which was regarded as circadian time 0 (CT0), and then treated with the complete medium again. The synchronized cells were cultured for n hours, denoted as CTn.17 Next, different treatments were performed on synchronized cells. The control group cells were cultured in the complete medium. The cells of the Aβ31‐35 group were treated with 5 μmol/L Aβ31‐35 (Abcam). The cells in the APN +Aβ31‐35 group were first pretreated with 10 ng/ml APN (Pepro Tech)for 1 h and then treated with 5 μmol/L Aβ31‐35. The cells in the APN group were treated with 10 ng/ml APN alone. In the LiCl (Sigma) + Aβ31‐35 group, the cells were pretreated with 30 μmol/L LiCl (a specific inhibitor of GSK3β18) for 20 min, followed by the addition of 5 μmol/L Aβ31‐35 (Figure 1B).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!